[1] WORLD HEALTH ORGANIZATION.Latent tuberculosis infection: updated and consolidated guidelines for programmatic management[EB/OL].[2028-04-15].https://www.who.int/tb/publications/2018/latent-tuberculosis-infection/en/. [2] 李媛媛, 谢晶晶, 李树涛, 等. 2024年WHO全球结核病报告:全球与中国关键数据分析[J/CD].新发传染病电子杂志, 2024, 9(6): 92-97. [3] AMERICAN THORACIC SOCIETY.Targeted tuberculin testing and treatment of latent tuberculosis infection[J]. MMWR Recomm Rep, 2000, 49(RR-6):1-51. [4] 中华人民共和国国家卫生健康委员会. 中国结核病预防控制工作技术规范(2020年版)[S]. 国卫办疾控函[2020] 279号, 2020-04-02. [5] 徐彩红, 赵雁林. 中国结核病预防性治疗指南[M]. 北京: 人民卫生出版社, 2023. [6] 国家卫生健康委员会办公厅, 教育部办公厅. 中国学校结核病防控指南(2020年版)[S]. 北京: 国家卫生健康委员会, 2020. [7] MODLIN RL, BLOOM BR. TB or not TB: that is no longer the question[J]. Sci Transl Med, 2013, 5(213):213sr6. [8] 唐佩军, 吴妹英. 结核分枝杆菌感染免疫应答与免疫逃逸机制的研究进展[J]. 结核病与肺部健康杂志, 2017, 6(2): 181-186. [9] 金鹏锋, 陈琳, 胡耀仁. T细胞耗竭在结核分枝杆菌感染中的作用[J]. 中华医院感染学杂志, 2019, 29(12): 1917-1920. [10] 沈洪波, 陈维政. 结核分枝杆菌潜伏感染的免疫机制及免疫干预研究进展[J]. 中华结核和呼吸杂志, 2016, 39(1): 47-51. [11] YOUNG DB, GIDEON HP, WILKINSON RJ.Eliminating latent tuberculosis[J]. Trends Microbiol, 2009, 17(5):183-188. [12] GENGENBACHER M, KAUFMANN SH.Mycobacterium tuberculosis: success through dormancy[J]. EMS Microbiol Rev, 2012, 36(3):514-532. [13] BANERJEE U, SANKAR S, SINGH A,et al.A multi-pronged computational pipeline for prioritizing drug target strategies for latent tuberculosis[J]. Front Chem, 2020, 8:593497. [14] STERLING TR, NJIE G, ZENNER D, et al.Guidelines for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020[J]. MMWR Recomm Rep, 2020, 69(1):1-11. [15] ZHANG X, LI Y, LIU B, et al.Effectiveness of preventive therapy for latent tuberculosis infection in China: A systematic review and meta-analysis[J]. Int J Infect Dis, 2019, 86: 1-8. [16] 刘宇红, 王黎霞, 张广宇. 儿童结核潜伏感染者发病风险的时间分布[J].中国防痨杂志, 2010, 32(3):145-149. [17] DODD PJ, GARDINER E, COGHLAN R, et al.Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study[J]. Lancet Glob Health, 2014, 2(8):e453-e459. [18] FOX GJ, BARRY SE, BRITTON WJ, et al.Contact investigation for tuberculosis: a systematic review and meta-analysis[J]. Eur Respir J, 2013, 41(1):140-156. [19] WANG L, ZHANG H, RUAN Y, et al.Tuberculosis prevalence in China, 1990-2010; a longitudinal analysis of national survey data[J]. Lancet, 2014, 383(9934):2057-2064. [20] HOUBEN RM, DODD PJ.The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling[J]. PLoS Med, 2016, 13(10): e1002152. |